Continuous glucose monitors (CGMs) were developed for people with type 1 diabetes who need real-time glucose data to manage insulin doses. They’re now being used by a much broader population — people with type 2 diabetes, prediabetes, and increasingly people without any diabetes diagnosis who want data on how food, exercise, and sleep affect their blood sugar.

Here’s what CGMs can actually tell you, and what they can’t.

What a CGM is

A CGM is a small sensor worn on the upper arm or abdomen. A tiny filament beneath the skin measures interstitial fluid glucose — not blood glucose directly, but the glucose in the fluid surrounding your cells, which correlates closely with blood glucose. The sensor transmits readings to a smartphone or receiver every few minutes, creating a continuous graph of glucose movement throughout the day and night.

Consumer-available options include the Dexterity and Libre platforms. In the U.S., some have required a prescription; regulatory status has been evolving. A 10–14 day wear period is typical before the sensor needs replacement.

What you can actually learn

The most valuable insight from CGMs for most users is post-meal glucose response — specifically, how different foods spike blood sugar and how long the spike lasts.

Standard blood tests can tell you your fasting glucose and three-month average (A1C), but they can’t tell you that your breakfast of whole-grain toast spikes you to 170 mg/dL while eggs and avocado barely moves the needle. CGM data makes that visible.

This is clinically valuable because, as research increasingly shows, post-meal spikes — not just fasting glucose or A1C — predict metabolic risk. People with normal A1C can have significant post-meal excursions that go undetected by standard testing.

A large 2020 study from King’s College London found that glucose responses to identical meals varied enormously between people — the same breakfast could spike one person modestly and another dramatically. CGM data makes it possible to identify your individual response patterns rather than relying on population averages.

What you can learn about lifestyle factors

Beyond food, CGMs reveal several things most people find surprising:

Exercise lowers glucose acutely, but intense exercise can cause a spike (cortisol-driven) before it lowers. Post-meal walks produce visible blunting of glucose peaks.

Poor sleep reliably raises fasting glucose and blunts the morning glucose recovery. Many users see this clearly after a bad night.

Stress — visible through elevated fasting glucose on difficult mornings — becomes more legible when you can see the number.

The limits

CGMs measure interstitial glucose, which lags blood glucose by 10–15 minutes. During rapid changes — during or immediately after eating — the reading can be temporarily inaccurate.

For non-diabetic users, context matters. Most glucose targets used in clinical settings (Time in Range, peak glucose thresholds) were developed for people with diabetes. Normal glucose physiology in healthy people includes some variability that gets pathologized when viewed through a diabetic lens. A spike to 150 mg/dL after a large meal isn’t necessarily problematic in a person without diabetes; clinical targets aren’t designed for that population.

The main value of CGM for the broader metabolic health audience is feedback-driven behavior change. Seeing what specific foods and habits do to your blood sugar in real time is motivating in a way that abstract A1C numbers often aren’t.


This content is for educational purposes only and is not medical advice. Consult your healthcare provider before making changes to your diet, supplements, or medications.